Position in JBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,715,272
+$1,647 QoQ
Shares Held
167,204
-36.7% QoQ
Ownership
0.263%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 153 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JBIO Over Time
Shares Held
Position Value (USD)
Derivatives in JBIO
reported options exposure · as of Mar 31, 2026CallValue
$157,360
CallShares
11,200
PutValue
$157,360
PutShares
11,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. JBIO ranks #86 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in JBIO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,715,272 | 167,204 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $157,360 | 11,200 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $157,360 | 11,200 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $3,713,625 | 264,315 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,617,253 | 558,474 | Shares | Defined | 2026-02-17 | |
| 2024-03-31 AVTE | — | 399,824 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 AVTE | — | 441,474 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 AVTE | — | 69,119 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 AVTE | — | 175,022 | Shares | Defined | 2023-05-15 | |
| 2021-09-30 AVTE | — | 53,872 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||